Benzinga | Oct 27, 2020 09:09AM EDT

CohBar To Participate At ROTH Capital COVID-19 Therapeutics In Development Event Oct. 28

MENLO PARK, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, and Chief Scientific Officer, Dr. Kenneth Cundy, will participate on the panel titled "Direct Antivirals and Other Agents Against SARS-CoV2 Virus" at the ROTH Capital COVID-19 Therapeutics in Development Event, being held virtually on October 28, 2020 at 7:30am PT. A live webcast of the presentation will be available for attendees who register at https://roth.zoom.us/webinar/register/WN_FF_LgnOeQmm7VsRye97DtQ.



The panelists will discuss key therapies that are novel and emerging approaches in development as potential treatments for COVID-19. Mr. Engle and Dr. Cundy will be joined by Dr. Tarek Hassanein, Professor of Medicine at UCSD, a hepatologist, and biotech company leaders from Aridis Pharmaceuticals, Hepion Pharmaceuticals, Durect Corporation, and Beyond Air. The panel will be moderated by ROTH analysts Scott Henry, CFA, Zegbeh Jallah, Ph.D., and Elemer Piros, Ph.D.

CohBar plans to present information on its CB5064 Analogs, which have shown potential as therapeutics in COVID-19 associated acute respiratory distress syndrome (ARDS), based on reduction of fluid accumulation, cytokine secretion, and neutrophil infiltration in a preclinical model of ARDS. CB5064 Analogs have been shown in vitro to activate the apelin receptor, which initiates a cell signaling pathway that has been shown in published preclinical studies to have broad protective effects. Apelin signaling may potentially reduce the severity of acute lung injury by reducing lung fluid accumulation, hypoxemia, and cytokine secretion, the primary consequences of severe COVID-19 infection leading to ARDS and downstream injury to the kidney, heart, and other organs.